Saurabh Saha - Mar 31, 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Stock symbol
CNTA
Transactions as of
Mar 31, 2024
Transactions value $
-$409,772
Form type
4
Date filed
4/2/2024, 04:17 PM
Previous filing
Feb 2, 2024
Next filing
May 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability -$410K -36.3K -4.01% $11.30 868K Mar 31, 2024 Direct F1, F2
holding CNTA Ordinary Shares 38K Mar 31, 2024 By trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.